ARGENT BIOPHARMA (UK) LTD

09750155
Active London

Wholesale of perfume and cosmetics

3 employees website.com
Life sciences and medical technology Wholesale of perfume and cosmeticsWholesale of pharmaceutical goods +2
A

ARGENT BIOPHARMA (UK) LTD

09750155

Wholesale of perfume and cosmetics

Founded 26 Aug 2015 Active London, United Kingdom 3 employees website.com
Life sciences and medical technology Wholesale of perfume and cosmeticsWholesale of pharmaceutical goodsResearch and experimental development on biotechnologyOther human health activities

Previous Company Names

MGC PHARMA (UK) LTD 26 Aug 2015 — 12 Apr 2024
Accounts Submitted 12 Apr 2026 Next due 29 Mar 2026 4 months overdue
Confirmation Submitted 27 Aug 2025 Next due 8 Sept 2026 2 months remaining
Net assets £-10M £1M 2025 year on year
Total assets £20M £722K 2025 year on year
Total Liabilities £29M £667K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor, Great Titchfield House 14-18 Great Titchfield Street London W1W 8BD United Kingdom

Website

www.example.com

Full company profile for ARGENT BIOPHARMA (UK) LTD (09750155), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 26 Aug 2015. Wholesale of perfume and cosmetics. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type full
Next accounts 29 Jun 2025
Due by 29 Mar 2026 4 months overdue

Balance Sheet & P&L (2016–2025)

Cash in Bank

£1.83k

Decreased by £1.43k (-44%)

Net Assets

-£9.73M

Increased by £1.39M (+12%)

Total Liabilities

£29.35M

Decreased by £666.59k (-2%)

Turnover

N/A

Employees

3

Decreased by 1 (-25%)

Debt Ratio

150%

Decreased by 9 (-6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Eastman, Anthony Neville ChisholmDirectorAustralianUnited Kingdom511 May 2016Active

Shareholders

Shareholders (1)

Mgc Pharmaceuticals Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Argent Biopharma Limited

Australia

Active
Notified 9 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ARGENT BIOPHARMA (UK) LTD Current Company
ZAM SOFTWARE LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Jun 2026OfficersAppointment of Mr Andrew Scott Chapman as director on 13 May 2026
12 Apr 2026AccountsAnnual accounts made up to 30 Jun 2025
20 Oct 2025OfficersTermination of Roby Reuven Zomer as director on 20 Oct 2025
27 Aug 2025Confirmation StatementConfirmation statement made on 25 Aug 2025 with no updates
2 Jul 2025AccountsAnnual accounts made up to 30 Jun 2024
17 Jun 2026 Officers

Appointment of Mr Andrew Scott Chapman as director on 13 May 2026

12 Apr 2026 Accounts

Annual accounts made up to 30 Jun 2025

20 Oct 2025 Officers

Termination of Roby Reuven Zomer as director on 20 Oct 2025

27 Aug 2025 Confirmation Statement

Confirmation statement made on 25 Aug 2025 with no updates

2 Jul 2025 Accounts

Annual accounts made up to 30 Jun 2024

Recent Activity

Latest Activity

Appointment of Mr Andrew Scott Chapman as director on 13 May 2026

1 weeks ago on 17 Jun 2026

Annual accounts made up to 30 Jun 2025

2 months ago on 12 Apr 2026

Termination of Roby Reuven Zomer as director on 20 Oct 2025

8 months ago on 20 Oct 2025

Confirmation statement made on 25 Aug 2025 with no updates

10 months ago on 27 Aug 2025

Annual accounts made up to 30 Jun 2024

12 months ago on 2 Jul 2025